John O'Bryan to Biological Products
This is a "connection" page, showing publications John O'Bryan has written about Biological Products.
Connection Strength
0.913
-
Targeting the "undruggable" RAS with biologics. Adv Cancer Res. 2022; 153:237-266.
Score: 0.718
-
Inhibition of RAS-driven signaling and tumorigenesis with a pan-RAS monobody targeting the Switch I/II pocket. Proc Natl Acad Sci U S A. 2022 10 25; 119(43):e2204481119.
Score: 0.195